Skip to main content

Myriad Genetics Inc

MYGN
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0000899923

No open-market purchases or sales by Myriad Genetics Inc insiders were filed in the last 90 days; 196 institutions reported holding it in 13F filings for Q2 2026, worth $507.8M in total; no superinvestor holds it.

13F holders, Q2 2024

Institutional positions in Myriad Genetics Inc as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
223
+39 vs. Q1 2024
Shares held
92.2M
−1.53M (−1.6%) vs. Q1 2024
Total value
$2.25B
+$256.2M (+12.8%) vs. Q1 2024
New holders
54
72 more added
Sold out
15
64 more reduced

2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting MYGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2024: 223 institutions
Q1 2021: 197 institutionsQ2 2021: 201 institutionsQ3 2021: 213 institutionsQ4 2021: 197 institutionsQ1 2022: 205 institutionsQ2 2022: 199 institutionsQ3 2022: 191 institutionsQ4 2022: 196 institutionsQ1 2023: 190 institutionsQ2 2023: 188 institutionsQ3 2023: 186 institutionsQ4 2023: 194 institutionsQ1 2024: 186 institutionsQ2 2024: 223 institutionsQ3 2024: 246 institutionsQ4 2024: 221 institutionsQ1 2025: 228 institutionsQ2 2025: 221 institutionsQ3 2025: 221 institutionsQ4 2025: 221 institutionsQ1 2026: 204 institutionsQ2 2026: 196 institutions
Value heldQ2 2024: $2.25B
Q1 2021: $2.25BQ2 2021: $2.31BQ3 2021: $2.56BQ4 2021: $2.16BQ1 2022: $1.99BQ2 2022: $1.46BQ3 2022: $1.55BQ4 2022: $1.17BQ1 2023: $1.91BQ2 2023: $1.88BQ3 2023: $1.33BQ4 2023: $1.72BQ1 2024: $2.00BQ2 2024: $2.25BQ3 2024: $2.48BQ4 2024: $1.27BQ1 2025: $832.9MQ2 2025: $480.5MQ3 2025: $639.8MQ4 2025: $567.1MQ1 2026: $519.2MQ2 2026: $507.8M
Institutions holding MYGN and their total value by quarter
QuarterHoldersValue
Q2 2026196$507.8M
Q1 2026204$519.2M
Q4 2025221$567.1M
Q3 2025221$639.8M
Q2 2025221$480.5M
Q1 2025228$832.9M
Q4 2024221$1.27B
Q3 2024246$2.48B
Q2 2024223$2.25B
Q1 2024186$2.00B
Q4 2023194$1.72B
Q3 2023186$1.33B
Q2 2023188$1.88B
Q1 2023190$1.91B
Q4 2022196$1.17B
Q3 2022191$1.55B
Q2 2022199$1.46B
Q1 2022205$1.99B
Q4 2021197$2.16B
Q3 2021213$2.56B
Q2 2021201$2.31B
Q1 2021197$2.25B

Institutions, Q2 2024

Shares, value and share of portfolio for each institution holding Myriad Genetics Inc; share changes are against Q1 2024.

Institutions holding MYGN in Q2 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Point72 Asset Management, L.P.839,456$20.5M0.07%+61,260+7.9%Added
Loomis Sayles & Co L P863,104$21.1M0.03%+863,104New
Goldman Sachs Group Inc877,874$21.5M0.00%−29,784−3.3%Reduced
Northern Trust Corp933,921$22.8M0.00%−22,435−2.3%Reduced
Charles Schwab Investment Management Inc1,041,928$25.5M0.00%+55,462+5.6%Added
D. E. Shaw & Co., Inc.1,126,747$27.6M0.04%−139,366−11.0%Reduced
Morgan Stanley1,372,637$33.6M0.00%−299,116−17.9%Reduced
Nuveen Asset Management, LLC1,378,224$33.7M0.01%−53,157−3.7%Reduced
Citadel Advisors LLC1,764,050$43.1M0.04%+397,503+29.1%Added
Disciplined Growth Investors Inc2,087,328$51.1M0.96%+10,035+0.5%Added
Geode Capital Management, LLC2,132,815$52.2M0.00%+116,443+5.8%Added
SEI Investments Co2,417,192$59.1M0.08%+124,007+5.4%Added
Artisan Partners Limited Partnership2,534,785$62.0M0.09%−34,951−1.4%Reduced
Bank of America Corp2,705,635$66.2M0.01%+60,873+2.3%Added
Dimensional Fund Advisors LP2,776,959$67.9M0.02%+75,445+2.8%Added
Glenview Capital Management, LLC3,748,432$91.7M1.94%−1,195,163−24.2%Reduced
Earnest Partners LLC4,072,018$99.6M0.47%+138,960+3.5%Added
State Street Corp4,343,757$106.2M0.00%−1,059,928−19.6%Reduced
Millennium Management LLC4,399,012$107.6M0.09%+324,974+8.0%Added
Camber Capital Management LP5,500,000$134.5M5.19%−2,135,000−28.0%Reduced
Wellington Management Group LLP8,262,425$202.1M0.04%+202,424+2.5%Added
Vanguard Group Inc10,064,671$246.2M0.00%+28,963+0.3%Added
BlackRock Inc.15,150,806$370.6M0.01%+271,487+1.8%Added
State Farm Mutual Automobile Insurance Co0$00.00%−446,061−100.0%Sold out
AMH Equity Ltd0$00.00%−110,000−100.0%Sold out
Texas Permanent School Fund0$00.00%−77,485−100.0%Sold out
American International Group, Inc.0$00.00%−47,331−100.0%Sold out
Pura Vida Investments, LLC0$00.00%−44,725−100.0%Sold out
Marshall Wace, LLP0$00.00%−33,557−100.0%Sold out
Toroso Investments, LLC0$00.00%−28,432−100.0%Sold out
SG Americas Securities, LLC0$00.00%−21,805−100.0%Sold out
Two Sigma Investments, LP0$00.00%−20,400−100.0%Sold out
Fox Run Management, L.L.C.0$00.00%−17,120−100.0%Sold out
Allianz Asset Management GmbH0$00.00%−16,300−100.0%Sold out
E Fund Management Co., Ltd.0$00.00%−11,776−100.0%Sold out
Metropolitan Life Insurance Co0$00.00%−4,619−100.0%Sold out
Smithfield Trust Co0$00.00%−84−100.0%Sold out
Nelson, Van Denburg & Campbell Wealth Management Group, LLC0$00.00%−16−100.0%Sold out
Credit Suisse AG––––Not filed
Cipher Capital LP––––Not filed